Vir Biotech gets U.S. funding for flu-prevention antibody
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
| (NASDAQ: VIR) | Delayed: 10.61 -0.69 (6.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.30 | 52 Week High | $ | |||
| Open | $11.21 | 52 Week Low | $ | |||
| Day High | $11.25 | P/E | N/A | |||
| Day Low | $10.60 | EPS | $ | |||
| Volume | 1,783,880 | |||||
